Large-scale testing (Phase 3)Ended earlyNCT05655520
What this trial is testing
Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease
Who this might be right for
Huntington's Disease
Supernus Pharmaceuticals, Inc. 153